JNK is required for effector T-cell function but not for T-cell activation

Nature

Volumn 405, Issue 6782, 2000, Pages 91-94

  Dong, Chen ^a   Yang, Derek D ^a,c   Tournler, Cathy ^b   Whitmarsh, Alan J ^b   Xu, Jie ^a   Davis, Roger J ^c   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0034604093     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35011091     Document Type: Article

References (16)

1. Ip, Y. T. & Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell Biol. 10, 205-219 (1998).
2. Li, B.,Tournier, C., Davis, R. J. & Flavell, R. A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18, 420-432 (1999).
3. Su, B. et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736 (1994).
4. Matsuda, S., Moriguchi, T., Koyasu, S. & Nishida, E. T-Lymphocyte activation signals for Interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273, 12378-123782 (1998).
5. Dong, C. et al. Defective T-cell differentiation in the absence of Jnk1. Science 282, 2092-2095 (1998).
6. Yang, D. D. et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575-585 (1998).
7. Kuan, C. Y. et al. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676 (1999).
8. 2-terminal kinase (JNK) gene expression during T-cell activation. J. Exp. Med. 191, 139-145 (2000).
9. Rincon, M. et al. The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med. 185, 1817-1830 (1998).
10. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A. & Horak, I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624 (1991).
11. Nourse, J. et al. Interleukin 2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573 (1994).
12. Gomez, J., Gonzalez, A., Martinez A., C. & Rebollo, A. IL-2-induced cellular events. Crit. Rev. Immunol. 18, 185-220 (1998).
13. Nishina, H. et al. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186, 941-953 (1997).
14. Swat, W. et al. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 8, 625-634 (1998).
15. 2-terminal kinase. Proc. Natl Acad. Sci. USA 94, 7337-7342 (1997).
16. Chow, C. -W., Dong, C., Flavell, R. A., & Davis, R. J. JNK inhibits targeting of protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol. (in the press).